Intranasal Dexmedetomidine as a Sedative Premedication for Patients Undergoing Suspension Laryngoscopy: A Randomized Double-Blind Study
Open Access
- 19 May 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (5) , e0154192
Abstract
Intranasal dexmedetomidine, a well-tolerated and convenient treatment option, has been shown to induce a favorable perioperative anxiolysis in children. We investigate intranasal dexmedetomidine as a sedative premedication for anesthesia recovery in an adult population. A prospective randomized controlled trial; 81 adult patients scheduled for elective suspension laryngoscopy received intranasal dexmedetomidine (1 μg∙kg–1) or a placebo 45–60 min before anesthetic induction. Extubation time was used as the primary outcome measure. Secondary variables included the levels of sedation (Observer’s Assessment of Alertness/Sedation scale, OAA/S) and anxiety (4-point anxiety score), anesthetic and analgesic requirements, hemodynamic fluctuations, and anesthesia recovery as well as side effects. The levels of sedation and anxiety differed significantly between the two groups at anesthesia pre-induction (p < 0.001 and = 0.001, respectively). Repeated-measure general linear model determined no significant interaction effect between group and time on the targeted concentration of propofol (F = 1.635, p = 0.200), but a significant main effect of group existed (F = 6.880, p = 0.010). A moderate but significant decrease in the heart rate was recorded in the dexmedetomidine group at pre-induction. Episodes of tachycardia and hypertension after tracheal intubation and extubation were more frequent in the placebo group. Intranasal dexmedetomidine as a sedative premedication induced a favorable perioperative anxiolysis without prolongation in anesthesia recovery; the hemodynamic effect was modest. ClinicalTrials.gov NCT 02108171Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (S2011010000587)
- Key Project from Guangzhou Health Bureau (20121A021007)
- National Natural Science Foundation of China (81271196)
- National Natural Science Foundation of China (81200709)
This publication has 36 references indexed in Scilit:
- Intranasal atomized dexmedetomidine for sedation during third molar extractionInternational Journal of Oral and Maxillofacial Surgery, 2013
- A randomised controlled trial of dexmedetomidine for suspension laryngoscopyAnaesthesia, 2012
- Incidence of cardiac arrest increases with the indiscriminate use of dexmedetomidine: A case series and review of published case reportsActa Anaesthesiologica Taiwanica, 2011
- Recovery Profiles from Dexmedetomidine as a General Anesthetic Adjuvant in Patients Undergoing Lower Abdominal SurgeryAnesthesia & Analgesia, 2008
- Dexmedetomidine causes prolonged recovery when compared with midazolam/fentanyl combination in outpatient shock wave lithotripsyEuropean Journal of Anaesthesiology, 2008
- Effects of preanesthetic administration of midazolam, clonidine, or dexmedetomidine on postoperative pain and anxiety in childrenPediatric Anesthesia, 2007
- Single‐dose dexmedetomidine attenuates airway and circulatory reflexes during extubationActa Anaesthesiologica Scandinavica, 2005
- The effect of pre-anaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient-controlled morphineEuropean Journal of Anaesthesiology, 2005
- Effect of pre‐operative anxiolysis on postoperative pain response in patients undergoing total abdominal hysterectomyAnaesthesia, 2002
- Oral Clonidine Premedication Reduces the Awakening Concentration of IsofluraneAnesthesia & Analgesia, 1998